AstraZeneca Pharma India Ltd.

NSE: ASTRAZEN | BSE: 506820 | ISIN: INE203A01020 | Industry: Pharmaceuticals
| Expensive Star
8934.5000 -140.00 (-1.54%)
NSE Sep 19, 2025 15:31 PM
Volume: 29,821
 

logo
AstraZeneca Pharma India Ltd.
edited 27 Nov 2020
8934.50
-1.54%
Business Standard
AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine using a lower dosage amid questions over the results from its late-stage study
Number of FII/FPI investors increased from 164 to 181 in Jun 2025 qtr.
Sputnik V to AstraZeneca: 'Combine your vaccine with ours to boost efficacy'
Business Today | 27 Nov 2020 9 more
More from AstraZeneca Pharma India Ltd.
Recommended
Five Interesting Stocks Today - September 19, 2025
The Baseline | 19 Sep 2025, 04:31PM
Market closes lower, JSW Energy arm to acquire Tidong Power
Trendlyne Marketwatch | 19 Sep 2025, 03:58PM
Bull run fizzles out: Multibagger count in Indian equities falls
The Baseline | 18 Sep 2025, 03:38PM